← brief for 2026-10-31 · Slowing decline

Empagliflozin's role in cardiometabolic disease treatment: an Egyptian expert's view.

Paper No results yet Peer reviewed

Key takeaways

This review looks at how empagliflozin works for heart and kidney disease in Egypt. It summarizes existing studies and guidelines. There are no new results from this paper.

Who did this work

Assaad-Khalil SH · Elmessallamy F · Elhadidy KE · El Hefnawy MH · Halawa MR · Zeitoun M · Hussein S · Elebrashy I

Source

Paper · PubMed, the drug frontier · 2026 Oct 30
https://pubmed.ncbi.nlm.nih.gov/42963793/